SB493 would increase and formalize state support for the Maryland Pediatric Cancer Fund by requiring the Governor to include a $5 million appropriation in the annual budget bill beginning in fiscal year 2027 and each year thereafter. The bill also expands the Fund’s financing sources to include money from the Cigarette Restitution Fund, and it authorizes those cigarette restitution dollars to be used for the pediatric cancer fund under the same budget-appropriation framework that governs other uses of that fund.
The bill keeps the Maryland Pediatric Cancer Fund dedicated to pediatric cancer research and limited administrative costs. It preserves the existing structure for grantmaking to physicians, hospitals, laboratories, educational institutions, and other eligible recipients, while maintaining the cap that no more than 5% of the Fund may be used for promotion and administration. It also continues the requirement for annual reporting to the General Assembly and regulation-making by the Secretary to implement the grant program.
Impact
SB493 would amend the Health – General Article and the State Finance and Procurement Article to create a continuing state budget obligation for pediatric cancer research funding and to add the Maryland Pediatric Cancer Fund as an authorized use of the Cigarette Restitution Fund. In practical terms, it would shift the Fund from relying only on direct appropriations and donations to also drawing from tobacco-settlement revenues, while preserving legislative control through the annual budget process. The bill would affect the Department of Health, the Secretary administering the Fund, grant recipients engaged in pediatric cancer research, and the broader allocation of Cigarette Restitution Fund dollars.
Sentiment
No committee transcripts or recorded votes were provided, so there is no direct evidence of floor or committee sentiment in the available materials. Based on the bill text, the measure appears strongly supportive of pediatric cancer research and funding stability, with a policy emphasis on sustained state investment beginning in fiscal 2027. The absence of recorded opposition or amendments in the provided context suggests no documented controversy in the materials supplied, though the funding source change could invite budgetary scrutiny in later proceedings.
Contention
The main policy issue is the source and timing of the funding. The bill requires a $5 million annual appropriation to the pediatric cancer fund starting in fiscal 2027 and authorizes up to $5 million from the Cigarette Restitution Fund, which may raise questions about competition with other tobacco-settlement priorities such as cancer prevention, Medicaid, tobacco cessation, and other public health programs. Another possible point of discussion is that the bill makes the appropriation mandatory in the Governor’s budget proposal but still subject to the annual budget process and legislative approval, which may be seen as balancing dedicated funding with fiscal flexibility.